Manual of signs, symptoms, methods and procedures for the assessment of the patient with SSc.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Clinical and Experimental Rheumatology

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 12889224
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Assessment of kidney involvement.

  2003cited by this paper
• Assessment of disease severity and prognosis.

  2003cited by this paper
• Assessment of skin, joint, tendon and muscle involvement.

  2003cited by this paper
• Assessment of lung involvement.

  2003cited by this paper
• Assessment of heart involvement.

  2003influential reference
• Assessment of gastrointestinal involvement.

  2003cited by this paper
• Assessment of vascular involvement.

  2003influential reference
• Predicting Mortality in Systemic Sclerosis: Analysis of a Cohort of 309 French Canadian Patients with Emphasis on Features at Diagnosis as Predictive Factors for Survival

  2002cited by this paper
• Disease severity of 100 patients with systemic sclerosis over a period of 14 years: using a modified Medsger scale

  2001cited by this paper
• European multicentre study to define disease activity criteria for systemic sclerosis.* I. Clinical and epidemiological features of 290 patients from 19 centres

  2001cited by this paper
• European multicentre study to define disease activity criteria for systemic sclerosis.* II. Identification of disease activity variables and development of preliminary activity indexes

  2001cited by this paper
• A disease severity scale for systemic sclerosis: development and testing.

  1999cited by this paper
• The palpable tendon friction rub: an important physical examination finding in patients with systemic sclerosis.

  1997cited by this paper
• Antinuclear antibody in systemic sclerosis (scleroderma).

  1996cited by this paper
• Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis.

  1995cited by this paper
• Criteria for rheumatic disease. Different types and different functions. The American College of Rheumatology Diagnostic and Therapeutic Criteria Committee.

  1994cited by this paper
• Skin thickness score in systemic sclerosis: an assessment of interobserver variability in 3 independent studies.

  1993cited by this paper
• Comparative studies of esophageal function in systemic sclerosis.

  1992cited by this paper
• Assessment of diastolic function of the heart: background and current applications of Doppler echocardiography. Part II. Clinical studies.

  1989cited by this paper
• Clinical correlations and prognosis based on serum autoantibodies in patients with systemic sclerosis.

  1988cited by this paper
• Scleroderma (systemic sclerosis): classification, subsets and pathogenesis.

  1988cited by this paper
• Pulmonary function in progressive systemic sclerosis. Comparison of CREST syndrome variant with diffuse scleroderma.

  1983cited by this paper
• Progressive systemic sclerosis subgroups: variable pulmonary features.

  1981cited by this paper
• A New, Simplified and Accurate Method for Determining Ejection Fraction with Two‐dimensional Echocardiography

  1981cited by this paper
• Preliminary criteria for the classification of systemic sclerosis (scleroderma).

  1980cited by this paper
• Investigation of small bowel transit time in man utilizing pulmonary hydrogen (H2) measurements.

  1975cited by this paper

• Myocardial perfusion defects in scleroderma detected by contrast-enhanced cardiovascular magnetic resonance

  2014cites this paper
• Impaired exercise performance in systemic sclerosis and its clinical correlations

  2010cites this paper
• Oropharyngolaryngeal Disorders in Scleroderma: Development and Validation of the SLS Scale

  2010cites this paper
• Increased serum levels of nitrotyrosine, a marker for peroxynitrite production, in systemic sclerosis.

  2007cites this paper
• Circulating levels of active transforming growth factor beta1 are reduced in diffuse cutaneous systemic sclerosis and correlate inversely with the modified Rodnan skin score.

  2005cites this paper